Grant & Eisenhofer recovered $1.6 billion in one of the largest False Claims Act settlements for a single drug
Plaintiff(s):
U.S. ex rel. McCoyd
Case type / claims:
Whistleblower action under the False Claims Act alleging Abbott unlawfully marketed its anti-epileptic drug Depakote to children and nursing-home patients.
Defendant(s):
Abbott Laboratories
Jurisdiction:
Western District of Virginia
Year:
2012
Outcome:
- Settled for $1.6 billion, one of the largest settlements for a single drug.
- The settlement included a corporate integrity agreement imposing significant compliance obligations on Abbott’s management to ensure lawful marketing practices.
